http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012214149-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76cc0835476b5e4f3244bfefcb06496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e444f8c9d778733c7f5ab969bb3ae6de http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_186ade5ae945aefe4c7df574ce6806dd |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-0088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0289 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-00 |
filingDate | 2012-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf0c9d1bd8170d7d779741680971fce8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c23699d23f7608a97ba56199a26e54f2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72af727418a05007aafefd1d4b63caed |
publicationDate | 2012-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2012214149-A1 |
titleOfInvention | Cyclic implant perfusion, cleaning and passivation process and implant produced thereby |
abstract | A method for perfusion of a porous implant which achieves efficient interpenetration of desired factors into and removal of undesirable factors from the pores of the implant, cleaning of the implant, efficient passivation of the implant, and the implant produced by such treatment. A system wherein the rate of pressure cycling, the fact of pressure cycling, and the amplitude of pressure cycling, results in highly cleaned tissues and other implants. Goals include between about a one to twelve log reduction in bacterial contamination, between about a one to fifteen log reduction in enveloped virus contamination, up to about a five log reduction in non-enveloped virus contamination, between about a two to tenfold reduction in endotoxin, maintenance of implant or graft biologic and biomechanical properties, absence of tissue toxicity due to cleaning solutions used, and reduced implant antigenicity. |
priorityDate | 1998-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 102.